Latest Northpond Ventures, LLC Stock Portfolio
$102Million
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Northpond Ventures, LLC and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Northpond Ventures, LLC reported an equity portfolio of $102.6 Millions as of 31 Mar, 2024.
The top stock holdings of Northpond Ventures, LLC are , VIGL, DNAY. The fund has invested 78.8% of it's portfolio in KYVERNA THERAPEUTICS INC and 14% of portfolio in VIGIL NEUROSCIENCE INC.
Northpond Ventures, LLC opened new stock positions in KYVERNA THERAPEUTICS INC.
The top stock holdings of Northpond Ventures, LLC are , VIGL, DNAY. The fund has invested 78.8% of it's portfolio in KYVERNA THERAPEUTICS INC and 14% of portfolio in VIGIL NEUROSCIENCE INC.
Northpond Ventures, LLC opened new stock positions in KYVERNA THERAPEUTICS INC.
New Buys
| Ticker | $ Bought |
|---|---|
| KYVERNA THERAPEUTICS INC | 80,864,800 |
New stocks bought by Northpond Ventures, LLC
Additions
Reductions
Sold off
Current Stock Holdings of Northpond Ventures, LLC
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| CADL | CANDEL THERAPEUTICS INC | 2.98 | 1,935,220 | 3,057,640 | UNCHANGED | 0.00 | |
| DNAY | TELESIS BIO INC | 4.22 | 9,844,130 | 4,331,420 | UNCHANGED | 0.00 | |
| VIGL | VIGIL NEUROSCIENCE INC | 14.00 | 4,214,500 | 14,371,400 | UNCHANGED | 0.00 | |
| KYVERNA THERAPEUTICS INC | 78.80 | 3,255,430 | 80,864,800 | NEW |